466 related articles for article (PubMed ID: 10023669)
1. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.
Chelbi-Alix MK; de Thé H
Oncogene; 1999 Jan; 18(4):935-41. PubMed ID: 10023669
[TBL] [Abstract][Full Text] [Related]
2. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
Sternsdorf T; Jensen K; Will H
J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
[TBL] [Abstract][Full Text] [Related]
3. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.
Parkinson J; Everett RD
J Virol; 2000 Nov; 74(21):10006-17. PubMed ID: 11024129
[TBL] [Abstract][Full Text] [Related]
4. Role and fate of PML nuclear bodies in response to interferon and viral infections.
Regad T; Chelbi-Alix MK
Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
[TBL] [Abstract][Full Text] [Related]
5. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
Perusina Lanfranca M; Mostafa HH; Davido DJ
J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
[TBL] [Abstract][Full Text] [Related]
6. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
Engelhardt OG; Ullrich E; Kochs G; Haller O
Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
[TBL] [Abstract][Full Text] [Related]
7. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
Negorev DG; Vladimirova OV; Maul GG
J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
[TBL] [Abstract][Full Text] [Related]
8. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
9. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
Müller S; Dejean A
J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977
[TBL] [Abstract][Full Text] [Related]
10. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
11. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.
Adamson AL; Kenney S
J Virol; 2001 Mar; 75(5):2388-99. PubMed ID: 11160742
[TBL] [Abstract][Full Text] [Related]
12. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection.
Puvion-Dutilleul F; Venturini L; Guillemin MC; de Thé H; Puvion E
Exp Cell Res; 1995 Dec; 221(2):448-61. PubMed ID: 7493645
[TBL] [Abstract][Full Text] [Related]
13. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms.
Everett RD; Freemont P; Saitoh H; Dasso M; Orr A; Kathoria M; Parkinson J
J Virol; 1998 Aug; 72(8):6581-91. PubMed ID: 9658103
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of the Replication of ICP0-Null Mutant Herpes Simplex Virus 1 and pp71-Deficient Human Cytomegalovirus by Epstein-Barr Virus Tegument Protein BNRF1.
Lu Y; Orr A; Everett RD
J Virol; 2016 Nov; 90(21):9664-9673. PubMed ID: 27535048
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
[TBL] [Abstract][Full Text] [Related]
16. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H
J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191
[TBL] [Abstract][Full Text] [Related]
17. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
Chelbi-Alix MK; Quignon F; Pelicano L; Koken MH; de Thé H
J Virol; 1998 Feb; 72(2):1043-51. PubMed ID: 9444998
[TBL] [Abstract][Full Text] [Related]
18. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.
Gu H; Roizman B
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8963-8. PubMed ID: 12855769
[TBL] [Abstract][Full Text] [Related]
19. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
Zheng Y; Gu H
J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
